Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.

MLA

Vuong, Jacqueline T., et al. “Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.” Journal of the American College of Cardiology, vol. 79, no. 6, Feb. 2022, pp. 577–93. EBSCOhost, https://doi.org/10.1016/j.jacc.2021.11.048.

APA

Vuong, J. T., Stein-Merlob, A. F., Nayeri, A., Sallam, T., Neilan, T. G., & Yang, E. H. (2022). Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 79(6), 577–593. https://doi.org/10.1016/j.jacc.2021.11.048

Chicago

Vuong, Jacqueline T, Ashley F Stein-Merlob, Arash Nayeri, Tamer Sallam, Tomas G Neilan, and Eric H Yang. 2022. “Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.” Journal of the American College of Cardiology 79 (6): 577–93. doi:10.1016/j.jacc.2021.11.048.